(Q36520517)

14 August 2017

Trends in prostate cancer in the United States (English)

1 reference

14 August 2017

United States of America

0 references

1 reference

Otis W Brawley

1

1 reference

14 August 2017

1 December 2012

1 reference

Journal of the National Cancer Institute Monographs

14 August 2017

1 reference

14 August 2017

2012

1 reference

14 August 2017

45

1 reference

14 August 2017

152-156

1 reference

Prostate cancer epidemiology in the United States

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

30 September 2017

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Rethinking screening for breast cancer and prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Screening for prostate cancer: have you had your cholesterol measured?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

The influence of finasteride on the development of prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

The role of increasing detection in the rising incidence of prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Trends and black/white differences in treatment for nonmetastatic prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Race and disparities in health

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540881

Prostate Cancer: Current Evidence Weighs Against Population Screening

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGS035

Impact of Patient Age on Biochemical Recurrence Rates Following Radical Prostatectomy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGS035

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

21 January 2018

1 reference

12 December 2020

Follow-up prostate cancer treatments after radical prostatectomy: a population-based study

1 reference

12 December 2020

Role of transurethral resection of the prostate in population-based prostate cancer incidence rates

1 reference

12 December 2020

Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry

1 reference

12 December 2020

10.1093/JNCIMONOGRAPHS/LGS035

Identifiers

DOI

1 reference

release_uexolg3vmnf5zgidxwdya2dsca

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uexolg3vmnf5zgidxwdya2dsca

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3540881

1 reference

PMC publication ID

3540881

14 August 2017

PubMed publication ID

23271766

1 reference

PMC publication ID

3540881